ReviewCancers2021

CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development.

Kenji HashimotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.